Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Life sciences
More from NICE
Home
NICE guidance
In development
In development: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic prioritisation
Filter
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Expected publication date
Expected publication date
From date
To date
Apply date filters
Area of interest
Area of interest
COVID-19 (10)
Type
Type
Guidance (425)
NICE advice (1)
Quality standard (9)
Guidance programme
Guidance programme
Clinical guidelines (27)
Diagnostics guidance (8)
Health technology evaluations (18)
HealthTech guidance (2)
Highly specialised technologies guidance (6)
Interventional procedures guidance (17)
Medical technologies guidance (10)
NICE guidelines (32)
Public health guidelines (1)
Technology appraisal guidance (342)
Advice programme
Advice programme
Medtech innovation briefings (1)
Apply filters
Showing 151 to 160 of 435
Sort by
Title
Date
Apply sorting
Guidance, NICE advice and quality standards in development
Title
Type
Expected publication date
Ex-situ machine perfusion devices for deceased donor liver transplants
Health technology evaluation
20 August 2026
Exploratory economic modelling of SARS-CoV-2 viral detection point of care tests and serology tests
Diagnostics guidance
TBC
Familial Breast Cancer: initial assessment and genetic testing (update)
NICE guideline
22 April 2027
Favezelimab–pembrolizumab for treating relapsed or refractory classical Hodgkin lymphoma after anti-PD-L1 treatment [ID6393]
Technology appraisal guidance
TBC
Fertility problems: assessment and treatment - update 1 and 2
NICE guideline
19 March 2026
Fezolinetant for treating vasomotor symptoms associated with the menopause [ID5071]
Technology appraisal guidance
TBC
Fidanacogene elaparvovec for treating moderately severe to severe haemophilia B [ID4032]
Technology appraisal guidance
TBC
Finerenone for treating heart failure with preserved or mildly reduced ejection fraction [ID6514]
Technology appraisal guidance
4 June 2026
Flow tDCS
Medtech innovation briefings
TBC
Fordadistrogene movaparvovec for treating Duchenne muscular dystrophy [ID6133]
Technology appraisal guidance
TBC
Previous page
1
…
14
15
Current page
16
17
18
…
44
Page
16
of
44
Next page
Results per page
10
25
50
All
Back to top